Siga Technologies INC Accounts Payable
Siga Technologies INC (SIGA) had Accounts Payable of $909.83 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Payable, Current $909.83K.
- 2026-03-31: Accounts Payable, Current $6.31M.
- 2025-12-31: Accounts Payable, Current $824.52K.
- 2025-09-30: Accounts Payable, Current $5.03M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $909.83K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $6.31M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $824.52K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $5.03M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $1.19M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $1.23M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $1.34M 10-K · filed 2026-03-10 |
| 2024-09-30 | $1.26M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.03M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $2.52M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $1.46M 10-K · filed 2025-03-11 |
| 2023-09-30 | $564.27K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $1.08M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.14M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $3.36M 10-K · filed 2024-03-12 |
| 2022-09-30 | $2.45M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $1.21M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $1.78M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $2.03M 10-K · filed 2023-03-02 |
| 2021-09-30 | $9.96M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $675.40K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $446.80K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $1.28M 10-K · filed 2022-03-03 |
| 2020-09-30 | $1.12M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $630.16K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $4.77M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $3.05M 10-K · filed 2021-03-04 |
| 2019-09-30 | $2.25M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $1.07M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $2.15M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $1.69M 10-K · filed 2020-03-05 |
| 2018-09-30 | $894.79K 10-Q · filed 2018-11-06 |
| 2018-06-30 | $1.41M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $432.21K 10-Q · filed 2018-05-04 |
| 2017-12-31 | $1.33M 10-K · filed 2019-03-06 |
| 2017-09-30 | $1.36M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $3.48M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $2.26M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $2.52M 10-K · filed 2018-03-06 |
| 2016-09-30 | $2.93M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $9.92M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $8.49M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $3.94M 10-K · filed 2017-03-07 |
| 2015-09-30 | $3.17M 10-Q · filed 2015-10-27 |
| 2015-06-30 | $4.78M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $3.55M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $3.38M 10-K · filed 2016-03-04 |
| 2014-09-30 | $680.93K 10-Q · filed 2014-11-04 |
| 2014-06-30 | $1.63M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $4.34M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $5.06M 10-K · filed 2015-03-06 |
| 2013-09-30 | $6.83M 10-Q · filed 2013-11-06 |
| 2013-06-30 | $16.26M 10-Q · filed 2013-08-05 |
| 2013-03-31 | $8.59M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $10.19M 10-K · filed 2014-03-10 |
| 2012-09-30 | $10.61M 10-Q · filed 2012-11-05 |
| 2012-06-30 | $10.05M 10-Q · filed 2012-08-06 |
| 2012-03-31 | $3.90M 10-Q · filed 2012-05-07 |
| 2011-12-31 | $2.28M 10-K/A · filed 2013-05-15 |
| 2011-09-30 | $2.22M 10-Q · filed 2011-11-08 |
| 2011-06-30 | $1.38M 10-Q · filed 2011-08-01 |
| 2010-12-31 | $2.88M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |